As of March 2024 Roche has a market cap of $204.76 Billion. This makes Roche the world's 56th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $204.76 B | -12.51% |
2023 | $234.05 B | -9.83% |
2022 | $259.55 B | -27.83% |
2021 | $359.63 B | 20.2% |
2020 | $299.20 B | 8.27% |
2019 | $276.35 B | 31.2% |
2018 | $210.64 B | -1.97% |
2017 | $214.86 B | 9.77% |
2016 | $195.74 B | -17.9% |
2015 | $238.41 B | 2.92% |
2014 | $231.65 B | -2.73% |
2013 | $238.15 B | -24.51% |
2012 | $315.46 B | 114.14% |
2011 | $147.31 B | 15.59% |
2010 | $127.44 B | -14.38% |
2009 | $148.85 B | 9.99% |
2008 | $135.33 B | -10.67% |
2007 | $151.50 B | -1.96% |
2006 | $154.53 B |
On Mar 28th, 2024 the market cap of Roche was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $381.20 B | 86.16% | ๐บ๐ธ USA |
Novartis NVS | $197.71 B | -3.44% | ๐จ๐ญ Switzerland |
Pfizer PFE | $157.13 B | -23.26% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $197.22 B | -3.69% | ๐บ๐ธ USA |
Amgen AMGN | $152.37 B | -25.59% | ๐บ๐ธ USA |
Sanofi SNY | $124.08 B | -39.40% | ๐ซ๐ท France |
Becton Dickinson BDX | $71.48 B | -65.09% | ๐บ๐ธ USA |
Merck MRK | $334.18 B | 63.20% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $87.98 B | -57.03% | ๐ฌ๐ง UK |